Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Bullboard Post History

by mrnormal


C.RVV

5 days left

“The FDA approval of the Phase 3 study to evaluate Bucillamine in the...

August 23, 2020

C.RVV

RE:Short Report...They're Back

Just curious if now that they've recovered will they continue? Seems...

August 22, 2020

C.RVV

RE:We look forward to unveil the final prototype in the coming

We may very well see a double whammy in the next few months as both the covid...

August 20, 2020

C.RVV

RE:The FDA is fast-tracking a second psilocybin drug to treat..

August presentation states: Q3 Pre-IND meeting with FDA for Psilocybin...

August 20, 2020

C.RVV

RE:RE:RE:RE:RE:RE:Here is the News :)

 267,075,483 shares fully diluted. That's it.

August 19, 2020

C.RVV

RE:RE:No new news

If you've been following this stock as closely as I have since March, you...

August 19, 2020

C.RVV

RE:Brand New Buyers will be joining us tomorrow :)

3:35 a.m. in Asia at the moment. Just wait till they wake up and hear the...

August 19, 2020

C.RVV

Revive has patent rights worldwide for Bucillamine

'Nuff said

August 19, 2020

C.RVV

RE:when it runs

From weak hands to strong.

August 19, 2020

C.RVV

RE:RE:RE:RVV has another phase 3 trial starting next month >>>

It's not a Revive Therapeutics Ltd. study!!!!

August 18, 2020

C.RVV

RE:RVV has another phase 3 trial starting next month >>>

Different company, not bucillamine. The drug bucillamine is only named...

August 18, 2020

C.RVV

fast-track the Phase 3 study

Our team and partners are working diligently to align our resources and...

August 18, 2020

C.RVV

RE:RE:RE:gap

Gaps needing filled is a myth

August 18, 2020

C.RVV

RE:Wait until September

Sadly true...

August 17, 2020

C.RVV

RE:RE:RE:The Most Frustrating Stock I HOLD.

I think you may benefit from some shroom therapy bub...

August 17, 2020

C.RVV

RE:The Most Frustrating Stock I HOLD.

HAHAHAHAHAHAH That ought to get Michael to work. Seriously, grow up. 

August 17, 2020

C.RVV

RE:gap

HAHAHAHAHA

August 17, 2020

C.RVV

RE:Just aired on 60 Minutes documentary on Psychedelic drugs

Link to Revive's subsidiary company that focuses on Psilocybin...

August 16, 2020

C.RVV

Updates to the August presentation

Updates to the August presentation https://secureservercdn.net/104.238.69...

August 16, 2020

C.RVV

RE:RE:RE:RE:RE:I’m curious to know how often are Stockwatch rumours correct

Yea, that twitter feed has been posting BS for a long time. Look where their...

August 16, 2020

Featured Company